Legal & General Group Plc Sells 195,163 Shares of Revvity Inc. $RVTY

Legal & General Group Plc trimmed its position in Revvity Inc. (NYSE:RVTY) by 42.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 262,609 shares of the company’s stock after selling 195,163 shares during the period. Legal & General Group Plc owned about 0.23% of Revvity worth $25,407,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in Revvity in the 2nd quarter worth about $32,000. Cromwell Holdings LLC grew its position in shares of Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after acquiring an additional 198 shares during the period. MUFG Securities EMEA plc bought a new position in shares of Revvity during the 2nd quarter valued at approximately $34,000. Headlands Technologies LLC bought a new position in shares of Revvity during the 2nd quarter valued at approximately $49,000. Finally, Smartleaf Asset Management LLC grew its position in shares of Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock valued at $58,000 after acquiring an additional 250 shares during the period. 86.65% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

RVTY has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Evercore increased their target price on shares of Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research report on Tuesday, February 3rd. Barclays upped their price target on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Robert W. Baird set a $117.00 price target on shares of Revvity in a research note on Wednesday, May 6th. Finally, The Goldman Sachs Group dropped their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. Four analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $107.73.

Revvity Price Performance

RVTY opened at $104.88 on Monday. The stock has a 50-day moving average price of $92.03 and a 200-day moving average price of $97.27. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $11.70 billion, a P/E ratio of 50.18, a PEG ratio of 2.25 and a beta of 1.11.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the prior year, the business earned $1.01 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts predict that Revvity Inc. will post 5.32 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is presently 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.